|Articles|December 3, 2008
Topical nepafenac as a treatment for CME
Topical nepafenac as a treatment for CME
Advertisement
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
IGS 2026: Clinical pearls for detecting pre-perimetric glaucoma
2
IGS 2026: Current clinical perspectives on optic disc drusen
3
Broadening horizons: Expanding your surgical portfolio with SMILE pro for Hyperopia
4
IGS 2026: The expanding role of artificial intelligence in ophthalmology
5
























